Skip to content

Validation of a Food Addiction Screening Test

Validation Study of a Rapid Screening Test of Food Addiction in Patients Suffering From Obesity and Healthy Volunteer

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04126239
Acronym
FAST - FR
Enrollment
1610
Registered
2019-10-15
Start date
2019-10-07
Completion date
2023-06-17
Last updated
2021-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Food Addiction, Obesity

Keywords

food Addiction, Obesity

Brief summary

Food addiction (FA) is a behavioral addiction characterized by a high consumption of palatable foods, which markedly activate the reward system, despite adverse consequences. FA was first described in 1956 but remains controversial. The Yale Food Addiction Scale (YFAS), developed by Gearhardt et al. in 2009, is currently regarded as the Gold Standard for FA screening. In a previous study, we established a Food Addiction Screening Test using artificial intelligence. The main objective of the present study is to validate the sensitivity, specificity and precision for FA diagnosis in a sample of patient suffering from obesity and healthy volunteers.

Interventions

OTHEROnline survey - questionnaire

Online survey - questionnaire

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI ≥ 30 * Able to consent

Exclusion criteria

* Non-french speaker * Patient unable to use internet tools

Design outcomes

Primary

MeasureTime frameDescription
FAST scoreBaselineScreening test to validate
YFAS 2.0BaselineScreening test to validate DSM-5 Yale Food Addiction Scale (YFAS 2.0)
BES scoreBaselineBinge Eating Scale scoring
DEBQ scoreBaselineDutch Eating Behaviour Questionnaire scoring

Countries

France

Contacts

Primary ContactSylvain ICETA, MD
sylvain.iceta@gmail.com4 27 85 60 11
Backup ContactEmmanuel Disse, PR
emmanuel.disse@chu-lyon.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026